Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × alirocumab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 73 Carboplatin 63 Pemetrexed 54 Cisplatin 40 Paclitaxel 35 durvalumab 23 Specimen Handling 23 Nivolumab 19 Magnetic Resonance Spectroscopy 18 Gemcitabine 17 osimertinib 14 Docetaxel 14 Bevacizumab 13 130-nm albumin-bound paclitaxel 12 atezolizumab 11 Cetuximab 10 cemiplimab 9 Taxes 9 Radiotherapy 9 Immunoglobulin G 9 Drug Therapy 9 Radiosurgery 8 Disulfides 8 Biopsy 8 tislelizumab 7 amivantamab 7 Observation 7 Fluorouracil 7 Oxaliplatin 6 Leucovorin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡